Company intelligence / Profile preview

Norlandia

Ownership: Private
Development stage: Commercial

Overview

Norilia utilizes industrial biotechnology processes such as enzymatic hydrolysis and fermentation to refine rest raw materials from the meat and egg industry, creating value-added ingredients for various industries. The company has successfully industrialized these processes at its Bioco facility for poultry byproduct refinement and continues to research further applications.

Modalities: Enzymatic hydrolysisFermentation
Industry: Non-Drug Biotech

Partnerships

Collaborations with biotech companies for process development are mentioned but specific partners are not listed in available sources.

Beyond the preview

Go deeper on Norlandia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norlandia.

Explore the full profile